Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 19, 2018

Primary Completion Date

March 5, 2021

Study Completion Date

June 30, 2023

Conditions
Plastic BronchitisProtein-Losing EnteropathiesHealthy
Interventions
DRUG

Treatment-inhaled tPA

Enrolled patients with acute plastic bronchitis (fibrin airway casts) will receive inhaled tPA treatment. The tPA regimen will consist of 5mg every six hours for a total of 72 hours.

Trial Locations (6)

19104

Children's Hospital of Philadelphia, Philadelphia

29425

Medical University of South Caroline, Charleston

45229

Cincinnati Children's Hospital, Cincinnati

48109

University of Michigan Mott Children's Hospital, Ann Arbor

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

94304

Lucile Packard Children's Hospital, Stanford University, Palo Alto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

University of Michigan

OTHER